Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Transplant Proc ; 50(4): 1041-1044, 2018 May.
Article in English | MEDLINE | ID: mdl-29731063

ABSTRACT

Although a nationwide activation system has been developed to increase deceased donor kidney transplantation (DDKT), there is still enormous discrepancy between transplant need and deceased donor supply in Korea, and therefore waiting time to DDKT is still long. We need to determine the current status of waiting time and the risk factors for long waiting time. We retrospectively analyzed the medical records of the patients on the wait list for DDKT at the Seoul National University Hospital from 2000 to 2017. Among 2,211 wait-listed patients, 606 (27.5%) received DDKT and mean waiting time to DDKT was 45 months. Among them, blood type A was most prevalent (35.6%) and type AB was the least (14.0%). Panel-reactive assay (PRA) was positive in 59 (11.0%) in the first transplant group and 25 (35.0%) in retransplant group. Waiting time in PRA-positive recipients was 63 and 66 months in the first transplant group and retransplant group, respectively. However, waiting time for patients with negative PRA was 42.8 months. Waiting time was shorter in blood type AB (39 months) than other types (46 months). Waiting time was the shortest in children and adolescents. Among patients who were still on the wait list, retransplantation candidates, especially with PRA higher than 50%, had longer waiting time than first transplant candidates. In conclusion, non-AB blood type, positive PRA, and adult age were significantly associated with long waiting time. Therefore, it is necessary to establish a management strategy such as tailored desensitization for highly sensitized patients on the wait list to reduce their waiting time.


Subject(s)
Blood Group Incompatibility , Kidney Transplantation/methods , Waiting Lists , Adolescent , Adult , Child , Female , Humans , Kidney Transplantation/adverse effects , Male , Republic of Korea , Retrospective Studies , Time Factors , Tissue Donors/supply & distribution , Transplants/supply & distribution
2.
Lett Appl Microbiol ; 66(5): 394-399, 2018 May.
Article in English | MEDLINE | ID: mdl-29444347

ABSTRACT

We produced a Pseudomonas veronii biofilm on the surface of a stainless steel that is inhibitory to Escherichia coli O157:H7. Pseudomonas veronii strain KACC 81051BP, isolated from lettuce, readily formed biofilm on the surface of stainless steel coupons (SSCs) immersed in tryptic soy broth at 25°C. Cells showed significantly (P ≤ 0·05) enhanced tolerance to desiccation stress (43% relative humidity (RH)) and retained antimicrobial activity against E. coli O157:H7. The number of E. coli O157:H7 (control; 4·1 ± 0·1 log CFU per coupon) on sterile SSCs decreased to 2·7 ± 0·2 log CFU per coupon after exposure to 43% RH at 25°C for 48 h, while the population of E. coli O157:H7 (4·1 ± 0·0 log CFU per coupon) on SSCs containing P. veronii biofilm decreased to below the theoretical detection limit (1·5 log CFU per coupon) within 24 h. The antimicrobial biofilm produced on stainless steel may have application in preventing cross-contamination by E. coli O157:H7 on other abiotic surfaces in food-contact environments. SIGNIFICANCE AND IMPACT OF THE STUDY: The presence of Escherichia coli O157:H7 on environmental surfaces of food manufacturing, transportation and storage facilities is a significant food safety concern because it can result in cross-contamination of food products. In this study, we developed a Pseudomonas veronii biofilm on the surface of a stainless steel that inhibits the growth of E. coli O157:H7. Since P. veronii in biofilm resists desiccation, it provides persistent antimicrobial activity. Information presented here provides novel and practical insights to developing biological strategies to inactivate E. coli O157:H7 on diverse surfaces in food processing and handling environments.


Subject(s)
Antibiosis/physiology , Biofilms/growth & development , Escherichia coli O157/growth & development , Pseudomonas/growth & development , Pseudomonas/physiology , Colony Count, Microbial , Desiccation , Escherichia coli O157/isolation & purification , Food Handling , Food Microbiology , Foodborne Diseases/microbiology , Foodborne Diseases/prevention & control , Lactuca/microbiology , Stainless Steel
3.
Br J Surg ; 104(12): 1628-1633, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28975600

ABSTRACT

BACKGROUND: A virtual reality (VR) tour of the operating theatre before anaesthesia could provide a realistic experience for children. This study was designed to determine whether a preoperative VR tour could reduce preoperative anxiety in children. METHODS: Children scheduled for elective surgery under general anaesthesia were randomized into a control or VR group. The control group received conventional information regarding anaesthesia and surgery. The VR group watched a 4-min video showing Pororo, the famous little penguin, visiting the operating theatre and explaining what is in it. The main outcome was preoperative anxiety, assessed using the modified Yale Preoperative Anxiety Scale (m-YPAS) before entering the operating theatre. Secondary outcomes included induction compliance checklist (ICC) and procedural behaviour rating scale (PBRS) scores during anaesthesia. RESULTS: A total of 69 children were included in the analysis, 35 in the control group and 34 in the VR group. Demographic data and induction time were similar in the two groups. Children in the VR group had a significantly lower m-YPAS score than those in the control group (median 31·7 (i.q.r. 23·3-37·9) and 51·7 (28·3-63·3) respectively; P < 0·001). During anaesthesia, the VR group had lower ICC and PBRS scores than the control group. CONCLUSION: This preoperative VR tour of the operating theatre was effective in alleviating preoperative anxiety and increasing compliance during induction of anaesthesia in children undergoing elective surgery. Registration number: UMIN000025232 (http://www.umin.ac.jp/ctr).


Subject(s)
Anxiety/prevention & control , Child, Hospitalized/psychology , Elective Surgical Procedures/psychology , Operating Rooms , User-Computer Interface , Anesthesia, General , Child , Child, Preschool , Female , Humans , Male , Patient Compliance
4.
Mucosal Immunol ; 10(3): 757-774, 2017 05.
Article in English | MEDLINE | ID: mdl-27554297

ABSTRACT

Nod-like receptor family, CARD domain-containing 4 (NLRC4) inflammasome activation is required for efficient clearance of intracellular pathogens through caspsase-1-dependent pyroptosis in macrophages. Although neutrophils have a critical role in protection from Pseudomonas aeruginosa infection, the mechanisms regulating inflammasome-mediated pyroptosis in neutrophils and its physiological role are largely unknown. We sought to determine the specific mechanisms regulating neutrophil pyroptosis in P. aeruginosa strain PAO1 (PAO1) lung infection and to identify the pathological role of this process. Nox2-/- models with reduced neutrophil antibacterial activity exhibited increased neutrophil pyroptosis, which was mediated by flagellin, a pathogenic PAO1 component. We also demonstrate that PAO1-induced pyroptosis depended on NLRC4 and Toll-like receptor 5 (TLR5) in neutrophils generated from Nlrc4-/- or Tlr5-/- mice. Our study reveals previously unknown mechanisms and physiological role of neutrophil pyroptosis during P. aeruginosa lung infection. Furthermore, our findings regarding neutrophil pyroptosis in the context of neutrophil dysfunction may explain the causes of acute and/or chronic infectious diseases discovered in immune-compromised patients.


Subject(s)
Apoptosis , Inflammasomes/metabolism , Lung/immunology , NADPH Oxidase 2/metabolism , Neutrophils/immunology , Pseudomonas Infections/immunology , Pseudomonas aeruginosa/immunology , Animals , Apoptosis Regulatory Proteins/genetics , Calcium-Binding Proteins/genetics , Flagellin/metabolism , Humans , Immunocompromised Host , Lung/microbiology , Mice , Mice, Inbred C57BL , Mice, Knockout , NADPH Oxidase 2/genetics , NLR Family, Pyrin Domain-Containing 3 Protein/genetics , Neutrophils/microbiology , Toll-Like Receptor 5/genetics
5.
Am. j. respir. crit. care med ; 194(6): 748-761, September 15, 2016.
Article in English | BIGG - GRADE guidelines | ID: biblio-966014

ABSTRACT

"BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease that primarily affects women. The purpose of these guidelines is to provide recommendations for the diagnosis and treatment of LAM. METHODS: Systematic reviews were performed to summarize evidence pertinent to our questions. The evidence was summarized and discussed by a multidisciplinary panel. Evidence-based recommendations were then formulated, written, and graded using the Grading of Recommendations, Assessment, Development, and Evaluation approach. RESULTS: After considering the panel's confidence in the estimated effects, the balance of desirable (i.e., benefits) and undesirable (i.e., harms and burdens) consequences of treatment, patient values and preferences, cost, and feasibility, recommendations were formulated for or against specific interventions. These included recommendations for sirolimus treatment and vascular endothelial growth factor D testing and recommendations against doxycycline and hormonal therapy. CONCLUSIONS: Evidence-based recommendations for the diagnosis and treatment of patients with LAM are provided. Frequent reassessment and updating will be needed."


Subject(s)
Humans , Male , Female , Lymphangioleiomyomatosis , Lymphangioleiomyomatosis/diagnosis , Biopsy , Tomography, X-Ray Computed , Lymphangioleiomyomatosis/therapy , Sirolimus , Sirolimus/therapeutic use , Vascular Endothelial Growth Factor D , Vascular Endothelial Growth Factor D/blood , Lung , Lung/diagnostic imaging
6.
Osteoarthritis Cartilage ; 23(12): 2288-2296, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26209889

ABSTRACT

OBJECTIVE: Hypoxia-inducible factor-2α (HIF-2α) transcriptionally upregulates Nampt in articular chondrocytes. NAMPT, which exhibits nicotinamide phosphoribosyltransferase activity, in turn causes osteoarthritis (OA) in mice by stimulating the expression of matrix-degrading enzymes. Here, we sought to elucidate whether HIF-2α activates the NAMPT-NAD(+)-SIRT axis in chondrocytes and thereby contributes to the pathogenesis of OA. METHODS: Assays of NAD levels, SIRT activity, reporter gene activity, mRNA, and protein levels were conducted in primary cultured mouse articular chondrocytes. Experimental OA in mice was induced by intra-articular (IA) injection of adenovirus expressing HIF-2α (Ad-Epas1) or NAMPT (Ad-Nampt). The functions of SIRT in OA were examined by IA co-injection of SIRT inhibitors or adenovirus expressing individual SIRT isoforms or shRNA targeting specific SIRT isoforms. RESULTS: HIF-2α activated the NAMPT-NAD(+)-SIRT axis in chondrocytes by upregulating NAMPT, which stimulated NAD(+) synthesis and thereby activated SIRT family members. The activated NAMPT-SIRT pathway, in turn, promoted HIF-2α protein stability by negatively regulating its hydroxylation and 26S proteasome-mediated degradation, resulting in increased HIF-2α transcriptional activity. Among SIRT family members (SIRT1-7), SIRT2 and SIRT4 were positively associated with HIF-2α stability and transcriptional activity in chondrocytes. This reciprocal regulation was required for the expression of catabolic matrix metalloproteinases (MMP3, MMP12, and MMP13) and OA cartilage destruction caused by IA injection of Ad-Epas1 Ad-Nampt. CONCLUSION: The reciprocal regulation of HIF-2α and the NAMPT-NAD(+)-SIRT axis in articular chondrocytes is involved in OA cartilage destruction caused by HIF-2α or NAMPT.


Subject(s)
Arthritis, Experimental/genetics , Basic Helix-Loop-Helix Transcription Factors/genetics , Cartilage, Articular/metabolism , Chondrocytes/metabolism , Cytokines/genetics , NAD/metabolism , Nicotinamide Phosphoribosyltransferase/genetics , Osteoarthritis, Knee/genetics , Sirtuin 1/genetics , Sirtuin 2/genetics , Animals , Arthritis, Experimental/metabolism , Basic Helix-Loop-Helix Transcription Factors/metabolism , Blotting, Western , Cytokines/metabolism , Immunoprecipitation , Matrix Metalloproteinase 12/genetics , Matrix Metalloproteinase 12/metabolism , Matrix Metalloproteinase 13/genetics , Matrix Metalloproteinase 13/metabolism , Matrix Metalloproteinase 3/genetics , Matrix Metalloproteinase 3/metabolism , Mice , Nicotinamide Phosphoribosyltransferase/metabolism , Osteoarthritis, Knee/metabolism , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sirtuin 1/metabolism , Sirtuin 2/metabolism , Sirtuins/genetics , Sirtuins/metabolism , Up-Regulation
7.
J Dent Res ; 94(8): 1135-42, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25940145

ABSTRACT

Chicken ovalbumin upstream promoter transcription factor 2 (COUP-TFII), an orphan nuclear receptor belonging to the steroid-thyroid hormone receptor superfamily, plays an important role in cell fate determination of various tissues. However, the specific role of COUP-TFII in tooth development has not yet been elucidated. In the present study, we aimed to explore the role of COUP-TFII in dentin sialophosphoprotein (DSPP) expression and matrix mineralization in odontoblast-lineage cells. In primary human dental pulp cells (HDPCs) and murine dental papilla-derived cells (MDPC-23) cultured in a mineralizing medium, the expression of COUP-TFII was induced along with the increased odontoblast-specific dentin matrix protein-1 (DMP-1) and DSPP expression. Endogenous expression of COUP-TFII in maxillary second molar germs of rats showed an increasing tendency as development of the tooth progressed. Also, COUP-TFII protein was detected in greater quantity in the odontoblastic layer of second molar germs than in that of third molar germs of rats. Overexpression of COUP-TFII using an adenoviral system upregulated the expression of odontoblast-specific genes with increased alkaline phosphatase activity and matrix mineralization in odontoblast-lineage cells. In contrast, knockdown of COUP-TFII using small interfering RNA decreased the expression of odontoblast-specific genes, which reduced matrix mineralization. Mechanistic studies revealed that COUP-TFII increased DSPP transcription by direct binding on the DSPP promoter. In addition, COUP-TFII physically interacted with the homeodomain transcription factor Msx2 and antagonistically regulated the Msx2 effect on DSPP promoter activity. Taken together, these results suggest that COUP-TFII has a stimulatory role in DSPP expression and matrix mineralization in odontoblast-lineage cells.


Subject(s)
COUP Transcription Factor II/metabolism , Dentinogenesis , Extracellular Matrix Proteins/metabolism , Odontoblasts/metabolism , Phosphoproteins/metabolism , Sialoglycoproteins/metabolism , Animals , Blotting, Western , Cell Differentiation , Cells, Cultured , Homeodomain Proteins/metabolism , Humans , Immunoprecipitation , Mice , Rats , Rats, Sprague-Dawley , Real-Time Polymerase Chain Reaction , Staining and Labeling , Transfection
8.
Br J Radiol ; 86(1032): 20130418, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24191123

ABSTRACT

OBJECTIVE: To determine and analyse the characteristics of contrast media adverse reactions (CM-ARs) reported in a hospital. METHODS: A retrospective review of CM-ARs from the electronic spontaneous adverse drug reaction (ADR) report system between January 2011 and August 2012 was conducted. CM-ARs were evaluated in terms of causality, severity, preventability and affected organs. Also, agreement and correlation among the tools used to evaluate CM-ARs were analysed. RESULTS: The overall reaction rate was 1.5% (n = 286). In total, 269 CM-ARs were identified. For ADR causality, 96.7% (n = 260) and 98.5% (n = 265) were evaluated as "probable" ADR using the Naranjo probability scale and the World Health Organization-Uppsala Monitoring Centre causality categories, whereas 98.1% (n = 264) were evaluated as "certain" with Korean algorithm v. II. Of these, 91.4% (n = 246) were mild in severity and 96.7% (n = 260) were unpreventable. Most patients (n = 233, 86.7%) could be managed with observation and/or simple treatment. The most frequent reaction (n = 383, 79.5%) was dermatological. Spearman's correlation coefficient was 0.667 (p < 0.01), and the agreement was 98.1% between the Naranjo scale and the World Health Organization-Uppsala Monitoring Centre categories. No relationship was seen between CM-AR severity and gender or between in- and outpatients. CONCLUSION: In our study, most CM-ARs were mild and managed with simple treatment. However, as the number of patients undergoing CT procedures continues to increase, it is essential to identify and observe patients at risk for CM-ARs to prevent severe ADRs. ADVANCES IN KNOWLEDGE: Continuous careful review of reporting and treatment protocols of CM-ARs is needed to prevent morbidity and mortality.


Subject(s)
Contrast Media/adverse effects , Adolescent , Adult , Adverse Drug Reaction Reporting Systems , Aged , Aged, 80 and over , Child , Female , Hospitals , Humans , Male , Middle Aged , Republic of Korea , Retrospective Studies , Severity of Illness Index , Skin Diseases/chemically induced , Young Adult
9.
Lett Appl Microbiol ; 55(3): 218-23, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22725610

ABSTRACT

AIMS: The objective of this study was to inactivate Bacillus cereus spores in sikhye using a modified tyndallization process involving injection with carbon dioxide (CO2). METHODS AND RESULTS: Heat tolerance of B. cereus spores in tryptic soy broth and sikhye was evaluated. The D(95°C) values of the B. cereus spores were 2·8-4·9 min, dependent of type of heating medium or inoculum level. The lethality of conventional heat treatment and modified tyndallization with or without CO2 injection against B. cereus spores in sikhye was determined. The order of effectiveness was modified tyndallization with CO2 > modified tyndallization without CO2 > conventional heat treatment. Modified tyndallization with CO2 reduced the number of B. cereus spores in sikhye by 5·8 log CFU ml⁻¹. The increased CO2 concentration and decreased pH of sikhye resulting from CO2 injection rapidly reverted to near-normal values after heat treatment. CONCLUSIONS: Modified tyndallization with CO2 was more effective than conventional heat treatment or modified tyndallization without CO2 in reducing B. cereus spores in sikhye. SIGNIFICANCE AND IMPACT OF THE STUDY: Results of this study will be useful when developing strategies to control B. cereus spores in sikhye and may have application to other beverages.


Subject(s)
Bacillus cereus/growth & development , Beverages/microbiology , Carbon Dioxide/chemistry , Food Handling/methods , Food Microbiology/methods , Bacillus cereus/physiology , Colony Count, Microbial , Hot Temperature , Oryza/microbiology , Spores, Bacterial/growth & development
10.
Cell Death Differ ; 19(3): 440-50, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21869830

ABSTRACT

Apoptosis of articular chondrocytes is associated with the pathogenesis of osteoarthritis (OA). Recently, we demonstrated that hypoxia-inducible factor (HIF)-2α, encoded by Epas1, causes OA cartilage destruction by regulating the expression of various matrix-degrading enzymes. Here, we investigated the involvement of HIF-2α in chondrocyte apoptosis and OA cartilage destruction. HIF-2α levels in human and mouse OA chondrocytes were markedly elevated in association with increased apoptosis of articular chondrocytes. Overexpression or knockdown of HIF-2α alone did not cause chondrocyte apoptosis. However, HIF-2α expression markedly increased chondrocyte apoptosis in the presence of an agonistic anti-Fas (CD95) antibody. HIF-2α enhanced Fas expression and potentiated downstream signaling pathways, increasing the activity of initiator and executioner caspases. Overexpression of HIF-2α in mouse cartilage tissue, either by intra-articular injection of Epas1 adenovirus (Ad-Epas1) or in the context of chondrocyte-specific Epas1 transgenic mice, increased chondrocyte apoptosis and cartilage destruction. In contrast, chondrocyte-specific knockout of Epas1 in mice suppressed DMM (destabilization of the medial meniscus)-induced chondrocyte apoptosis and inhibited OA cartilage destruction. Moreover, Fas-deficient mice exhibited diminished chondrocyte apoptosis and OA cartilage destruction in response to Ad-Epas1 injection or DMM surgery. Taken together, our results demonstrate that HIF-2α potentiates Fas-mediated chondrocyte apoptosis, which is associated with OA cartilage destruction.


Subject(s)
Apoptosis , Basic Helix-Loop-Helix Transcription Factors/metabolism , Cartilage/metabolism , Chondrocytes/metabolism , Osteoarthritis/metabolism , fas Receptor/biosynthesis , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Cartilage/pathology , Cells, Cultured , Chondrocytes/pathology , Gene Expression Regulation/genetics , Humans , Mice , Mice, Transgenic , Osteoarthritis/genetics , Osteoarthritis/pathology , Signal Transduction/genetics , fas Receptor/genetics
11.
J Appl Microbiol ; 111(6): 1465-72, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21988171

ABSTRACT

AIMS: To determine survival and colonization of Escherichia coli O157:H7 on spinach leaves as affected by inoculum level and carrier, temperature and relative humidity (r.h.). METHODS AND RESULTS: Spinach leaves were inoculated with suspensions of E. coli O157:H7 in distilled water (DW) and 0.1% peptone water (PW) and incubated at 4, 12 and 25°C and 43, 85 and 100% r.h. The number of E. coli O157:H7 on leaves (5.6 or 1.9 log CFU per leaf) inoculated using DW as a carrier medium increased significantly at 25°C and 100% r.h. within 120 h but remained constant or decreased significantly under other test conditions. E. coli O157:H7 on leaves (5.4 log CFU per leaf) inoculated using PW as a carrier increased significantly within 72 and 24 h, respectively, at 12 or 25°C and 100% r.h.; counts using a low inoculum (2.2 log CFU per leaf) increased significantly within 24 h at 25°C. CONCLUSIONS: Escherichia coli O157:H7 can colonize on spinach leaves at 12 or 25°C in a 100% r.h. environment. Organic matter in the inoculum carrier may provide protection and nutrients which enhance survival and colonization. SIGNIFICANCE AND IMPACT OF THE STUDY: Colonization of E. coli O157:H7 on spinach leaves as affected by organic matter in the inoculum, temperature and r.h. was determined. These observations will be useful when developing strategies to prevent growth of E. coli O157:H7 on pre- and postharvest spinach.


Subject(s)
Escherichia coli O157/growth & development , Food Microbiology , Humidity , Spinacia oleracea/microbiology , Temperature , Colony Count, Microbial , Consumer Product Safety , Food Contamination/analysis , Plant Leaves/microbiology
12.
Lett Appl Microbiol ; 53(4): 424-9, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21770990

ABSTRACT

AIMS: To assess the effectiveness of sequential treatments of radish seeds with aqueous chlorine dioxide (ClO(2) ) and dry heat in reducing the number of Escherichia coli O157:H7. METHODS AND RESULTS: Radish seeds containing E. coli O157:H7 at 5.5 log CFU g(-1) were treated with 500 µg ml(-1) ClO(2) for 5 min and subsequently heated at 60 °C and 23% relative humidity for up to 48 h. Escherichia coli O157:H7 decreased by more than 4.8 log CFU g(-1) after 12 h dry-heat treatment. The pathogen was inactivated after 48 h dry-heat treatment, but the germination rate of treated seeds was substantially reduced from 91.2 ± 5.0% to 68.7 ± 12.3%. CONCLUSIONS: Escherichia coli O157:H7 on radish seeds can be effectively reduced by sequential treatments with ClO(2) and dry heat. To eliminate E. coli O157:H7 on radish seeds without decreasing the germination rate, partial drying of seeds at ambient temperature before dry-heat treatment should be investigated, and conditions for drying and dry-heat treatment should be optimized. SIGNIFICANCE AND IMPACT OF THE STUDY: This study showed that sequential treatment with ClO(2) and dry-heat was effective in inactivating large numbers of E. coli O157:H7 on radish seeds. These findings will be useful when developing sanitizing strategies for seeds without compromising germination rates.


Subject(s)
Chlorine Compounds/toxicity , Escherichia coli O157/drug effects , Hot Temperature , Oxides/toxicity , Raphanus/microbiology , Colony Count, Microbial , Desiccation/methods , Escherichia coli O157/growth & development , Germination , Seeds/microbiology , Water
13.
J Bone Joint Surg Br ; 93(6): 782-7, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21586777

ABSTRACT

We compared the complications and outcome of tibial lengthening using the Ilizarov method with and without the use of a supplementary intramedullary nail. In a retrospective case-matched series assembled from 176 patients with tibial lengthening, we matched 52 patients (26 pairs, group A with nail and group B without) according to the following criteria in order of importance: 1) difference in amount of lengthening (± 2 cm); 2) percentage difference in lengthening (± 5%); 3) difference in patient's age (± seven years); 4) aetiology of the shortening, and 5) level of difficulty in obtaining the correction. The outcome was evaluated using the external fixator index, the healing index and an outcome score according to the criteria of Paley. It was found that some complications were specific to group A or B respectively, but others were common to both groups. The outcome was generally better in lengthenings with a nail, although there was a higher incidence of rectifiable equinus deformity in these patients.


Subject(s)
Bone Nails , Ilizarov Technique/adverse effects , Leg Length Inequality/surgery , Adolescent , Adult , Age Factors , Contracture/etiology , Female , Humans , Ilizarov Technique/instrumentation , Knee Joint , Leg Length Inequality/etiology , Male , Retrospective Studies , Surgical Wound Infection/etiology , Treatment Outcome , Young Adult
14.
Lett Appl Microbiol ; 51(6): 665-70, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21054447

ABSTRACT

AIMS: To fabricate a DNA chip containing random fragments of genomic DNA of Yersinia enterocolitica and to verify its diagnostic ability. METHODS AND RESULTS: A DNA microarray chip was fabricated using randomly fragmented DNA of Y. enterocolitica. Chips were hybridized with genomic DNA extracted from other Y. enterocolitica strains, other Yersinia spp. and bacteria in different genera. Genomic DNA extracted from Y. enterocolitica showed a significantly higher hybridization rate compared with DNA of other Yersinia spp. or bacterial genera, thereby distinguishing it from other bacteria. CONCLUSIONS: A DNA chip containing randomly fragmented genomic DNA from Y. enterocolitica can detect Y. enterocolitica and clearly distinguish it from other Yersinia spp. and bacteria in different genera. SIGNIFICANCE AND IMPACT OF THE STUDY: A microarray chip containing randomly fragmented genomic DNA of Y. enterocolitica was fabricated without sequence information, and its diagnostic ability to identify Y. enterocolitica was verified.


Subject(s)
Oligonucleotide Array Sequence Analysis/methods , Yersinia enterocolitica/genetics , Cluster Analysis , DNA Probes/genetics , DNA, Bacterial/analysis , Principal Component Analysis , Species Specificity , Yersinia enterocolitica/classification , Yersinia enterocolitica/isolation & purification
15.
Int J Clin Pharmacol Ther ; 48(4): 259-69, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20353747

ABSTRACT

BACKGROUND: Clopidogrel, a thienopyridine derivative, is an inhibitor of platelet aggregation induced by adenosine diphosphate (ADP). We compared the pharmacokinetics and the antiplatelet effect of two clopidogrel formulations (clopidogrel besylate (test) and clopidogrel bisulfate (reference)). SUBJECTS AND METHODS: The study was conducted in 40 healthy subjects in a randomized, open-label, 2-period crossover manner. Each subject received a single loading dose of 150 mg clopidogrel on Day 1 followed by a daily dose of 75 mg clopidogrel from Day 2 to Day 7. After the first dose blood samples for pharmacokinetic analysis of clopidogrel and SR26334 were collected over 24 h. The pharmacodynamic variables, i.e., the inhibition of ADP-induced platelet aggregation, were measured over 264 h. RESULTS: No serious adverse events occurred during the study period. The mean plasma concentration-time profiles of clopidogrel and SR26334 for the two formulations were comparable. The 90% confidence intervals (CIs) for the log-transformed ratios for pharmacokinetic parameters (Cmax and AUC) of SR26334 fell within the predefined pharmacokinetic equivalence range of 80 - 125%. However, the upper limits of 90% CI of Cmax and AUC for clopidogrel exceeded the equivalence range. The two formulations showed similar antiplatelet profiles. The 90% CIs of DeltaEmax and DeltaAUEC of platelet aggregation inhibition fell within the equivalence range of 80 - 125%. CONCLUSION: Both clopidogrel formulations were well-tolerated. The study population showed no serious AEs. The test formulation proved pharmacokinetically non-inferior to the reference formulation. The test formulation showed an antiplatelet effect on ADP-induced platelet aggregation similar to the reference formulation. The two formulations were considered pharmacodynamically equivalent in terms of platelet aggregation inhibition.


Subject(s)
Platelet Aggregation Inhibitors/administration & dosage , Platelet Aggregation Inhibitors/pharmacokinetics , Ticlopidine/analogs & derivatives , Adult , Area Under Curve , Chemistry, Pharmaceutical , Clopidogrel , Cross-Over Studies , Double-Blind Method , Half-Life , Humans , Male , Platelet Aggregation/drug effects , Platelet Aggregation Inhibitors/pharmacology , Ticlopidine/administration & dosage , Ticlopidine/pharmacokinetics , Ticlopidine/pharmacology , Young Adult
16.
Int J Clin Pharmacol Ther ; 48(4): 291-5, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20353751

ABSTRACT

BACKGROUND AND AIMS: Leflunomide is a disease-modifying antirheumatic drug (DMARD) with comparable efficacy to methotrexate in the treatment of rheumatoid arthritis. We compared the pharmacokinetic characteristics of two leflunomide formulations in healthy subjects and assessed whether these formulations were bioequivalent. SUBJECTS AND METHODS: A randomized, two-way, crossover study was conducted in 24 healthy male volunteers to compare the pharmacokinetics of two leflunomide formulations after administration of a single 20 mg dose of each drug with a 7 week washout period. Blood samples for the analysis of A77 1726, the main active metabolite of leflunomide, were obtained 624 h after drug administration. RESULTS: After administering a single dose of 20 mg of each leflunomide formulation, the mean AUC(0-t) and Cmax values of A771726 were 487.3 +/- 167.6 microg*h/ml and 2.24 +/- 0.85 microg/ml for the reference formulation and 468.5 +/- 148.6 microg*h/ml and 1.98 +/- 0.45 microg/ml for the test formulation, respectively. The 90% confidence intervals of the test/reference mean ratios for AUC(0-t), AUC(0-inf), and Cmax fell within the predetermined equivalence range of 0.8 - 1.25. No serious adverse events occurred during the study period. CONCLUSIONS: The two leflunomide formulations showed similar pharmacokinetic profiles in terms of A77 1726, and the test formulation was found to be bioequivalent to the reference formulation with respect to the rate and extent of leflunomide absorption.


Subject(s)
Antirheumatic Agents/administration & dosage , Antirheumatic Agents/pharmacokinetics , Isoxazoles/administration & dosage , Isoxazoles/pharmacokinetics , Adult , Area Under Curve , Chromatography, High Pressure Liquid , Cross-Over Studies , Double-Blind Method , Half-Life , Humans , Leflunomide , Male , Spectrophotometry, Ultraviolet , Therapeutic Equivalency , Young Adult
17.
Br J Anaesth ; 104(3): 344-50, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20042475

ABSTRACT

BACKGROUND: In this double-blind, randomized, placebo-controlled study, we evaluated the effects of magnesium sulphate on neuromuscular blocking agent requirements and analgesia in children with cerebral palsy (CP). METHODS: We randomly divided 61 children with CP undergoing orthopaedic surgery into two groups. The magnesium group (Group M) received magnesium sulphate 50 mg kg(-1) i.v. as a bolus and 15 mg kg(-1) h(-1) by continuous infusion during the operation. The control group (Group S) received the same amount of isotonic saline. Rocuronium was administered 0.6 mg kg(-1) before intubation and 0.1 mg kg(-1) additionally when train-of-four counts were 2 or more. I.V. fentanyl and ketorolac were used to control postoperative pain. Total infused analgesic volumes and pain scores were evaluated at postoperative 30 min, and at 6, 24, and 48 h. RESULTS: The rocuronium requirement of Group M was significantly less than that of Group S [0.29 (0.12) vs 0.42 (0.16) mg kg(-1) h(-1), P<0.05]. Cumulative analgesic consumption in Group M was significantly less after operation at 24 and 48 h (P<0.05), and pain scores in Group M were lower than in Group S during the entire postoperative period (P<0.05). Serum magnesium concentrations in Group M were higher until 24 h after operation (P<0.05). The incidence of postoperative nausea and vomiting and rescue drug injections was similar in the two groups. No shivering or adverse effects related to hypermagnesaemia were encountered. CONCLUSIONS: I.V. magnesium sulphate reduces rocuronium requirements and postoperative analgesic consumption in children with CP.


Subject(s)
Analgesics/pharmacology , Cerebral Palsy/complications , Magnesium Sulfate/pharmacology , Neuromuscular Nondepolarizing Agents/administration & dosage , Pain, Postoperative/prevention & control , Adolescent , Analgesics/blood , Analgesics/therapeutic use , Analgesics, Opioid/administration & dosage , Androstanols/administration & dosage , Cerebral Palsy/surgery , Child , Child, Preschool , Double-Blind Method , Drug Administration Schedule , Drug Synergism , Female , Humans , Intraoperative Care/methods , Magnesium Sulfate/blood , Magnesium Sulfate/therapeutic use , Male , Osteotomy , Pain Measurement/methods , Rocuronium
18.
Br J Anaesth ; 103(4): 490-5, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19687032

ABSTRACT

BACKGROUND: This prospective, randomized study was designed to compare remifentanil and magnesium sulphate during middle ear surgery in terms of postoperative pain and other complications. METHODS: Eighty patients undergoing middle ear surgery were enrolled in the study. Patients were randomized into two groups of 40 to receive remifentanil (Group R) or magnesium sulphate (Group M) infusion. Propofol 2 mg kg(-1) was administered to induce anaesthesia, which was maintained using sevoflurane. Group R received a continuous infusion of remifentanil titrated between 3 and 4 ng ml(-1) using target-controlled infusion, whereas Group M received an i.v. magnesium sulphate bolus of 50 mg kg(-1) followed by a 15 mg kg(-1) h(-1) continuous infusion to maintain a mean arterial pressure (MAP) between 60 and 70 mm Hg. Haemodynamic variables, surgical conditions, postoperative pain, and adverse effects, such as postoperative nausea and vomiting (PONV) and shivering, were recorded. RESULTS: Controlled hypotension was well maintained in both groups. MAP and heart rate were higher in Group R than in Group M after operation. Surgical conditions were not different between the two groups. Postoperative pain scores were significantly lower in Group M than in Group R (P<0.05). Seventeen patients in Group R (43%) and seven patients in Group M (18%) developed PONV (P=0.01). CONCLUSIONS: Both magnesium sulphate and remifentanil when combined with sevoflurane provided adequate controlled hypotension and proper surgical conditions for middle ear surgery. However, patients administered magnesium sulphate had a more favourable postoperative course with better analgesia and less shivering and PONV.


Subject(s)
Antihypertensive Agents/therapeutic use , Ear, Middle/surgery , Hypotension, Controlled/methods , Magnesium Sulfate/therapeutic use , Piperidines/therapeutic use , Adult , Analgesics/therapeutic use , Analgesics, Opioid/therapeutic use , Anesthesia, General/methods , Blood Pressure/drug effects , Female , Heart Rate/drug effects , Humans , Male , Middle Aged , Pain, Postoperative/prevention & control , Postoperative Nausea and Vomiting/prevention & control , Prospective Studies , Remifentanil
19.
Acta Radiol ; 49(10): 1104-11, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18855166

ABSTRACT

BACKGROUND: When a palpable breast mass is detected, a biopsy is usually performed even if the mass reveals probably benign morphologic features on imaging, as there is relatively little data reporting the outcome of such breast masses. PURPOSE: To determine the negative predictive value for sonographic evaluation of palpable breast masses with probably benign morphology, and to assess whether follow-up may be an acceptable alternative to immediate biopsy. MATERIAL AND METHODS: Of the 1399 sonograms of palpable masses from January 2004 to September 2005, there were 397 patients with masses of probably benign morphology. This study included 274 of these patients (age range 12-64 years, mean age 34 years) with 312 palpable masses that were pathologically confirmed by fine-needle aspiration (n=7), ultrasound (US)-guided core needle biopsy (n=180), or surgical biopsy (n=125). The false-negative rate, negative predictive value (NPV), and 95% confidence interval (CI) were calculated using the SPSS statistical software package for Windows, version 12.0. A P value <0.05 was considered statistically significant. RESULTS: Of the 312 masses, there were 310 benign lesions and two malignancies, resulting in a false-negative rate of 0.6% (NPV 99.4%, P value=0.0432, 95% CI 0.0-1.5%). CONCLUSION: The negative predictive value of sonography for palpable breast masses with probably benign morphology is high (99.4%). Therefore, short-term imaging follow-up can be an acceptable alternative to immediate biopsy, similar to the management of nonpalpable probably benign lesions (BI-RADS category 3).


Subject(s)
Adenomyoepithelioma/diagnosis , Breast Neoplasms/diagnosis , Breast/pathology , Fibroadenoma/diagnosis , Hamartoma/diagnosis , Papilloma, Intraductal/diagnosis , Ultrasonography, Mammary , Adolescent , Adult , Biopsy , Biopsy, Fine-Needle , Biopsy, Needle , Breast/surgery , Breast Diseases/diagnosis , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Child , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Middle Aged , Predictive Value of Tests , Young Adult
20.
Br J Anaesth ; 100(3): 397-403, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18276652

ABSTRACT

BACKGROUND: This randomized, double-blind, prospective study was undertaken to evaluate the effects of magnesium sulphate on anaesthetic requirements and postoperative analgesia in patients undergoing total i.v. anaesthesia (TIVA). METHODS: Fifty patients who underwent gynaecological surgery were randomly divided into two groups. Before induction of anaesthesia, the magnesium group (Group M) received magnesium sulphate 50 mg kg(-1) i.v. as a bolus and then 15 mg kg(-1) h(-1) i.v. by continuous infusion. The control group (Group S) received the same amount of isotonic saline. TIVA (propofol+remifentanil) was administered under bispectral index monitoring during anaesthesia induction and maintenance. Rocuronium was administered before orotracheal intubation and during surgery when the train-of-four count was 2 or more. After operation, patient-controlled analgesia with a solution of ketorolac and morphine was used and the consumption of this solution was recorded. Pain scores at rest and upon movement were evaluated 30 min, 4, 24, and 48 h after surgery. RESULTS: Patients in Group M required less rocuronium than those in Group S [mean (SD) 0.44 (0.09) vs 0.35 (0.07) microg kg(-1) min(-1), P<0.05]. The total amounts of propofol and remifentanil administered were similar in the two groups. Postoperative pain scores, cumulative analgesic consumption, and shivering incidents were significantly lower in Group M (P<0.05). Mean arterial pressure just after intubation and during the immediate postoperative period was also significantly lower in Group M (P<0.05). CONCLUSIONS: I.v. magnesium sulphate during TIVA reduced rocuronium requirement and improved the quality of postoperative analgesia.


Subject(s)
Analgesics/pharmacology , Anesthetics, Intravenous/administration & dosage , Magnesium Sulfate/pharmacology , Pain, Postoperative/prevention & control , Adult , Analgesia, Patient-Controlled/methods , Anesthesia, Intravenous , Double-Blind Method , Drug Administration Schedule , Female , Gynecologic Surgical Procedures , Humans , Middle Aged , Pain Measurement/methods , Piperidines/administration & dosage , Propofol/administration & dosage , Remifentanil
SELECTION OF CITATIONS
SEARCH DETAIL
...